ZNF514 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.571800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.567800E-01
Normal-vs-Stage2
4.292600E-01
Normal-vs-Stage3
2.259200E-01
Normal-vs-Stage4
4.541400E-01
Stage1-vs-Stage2
9.081000E-01
Stage1-vs-Stage3
9.228300E-02
Stage1-vs-Stage4
5.227800E-01
Stage2-vs-Stage3
2.050200E-01
Stage2-vs-Stage4
6.530600E-01
Stage3-vs-Stage4
3.817800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.023200E-01
Normal-vs-AfricanAmerican
3.615600E-01
Normal-vs-Asian
2.113800E-01
Caucasian-vs-AfricanAmerican
3.406200E-01
Caucasian-vs-Asian
3.132200E-01
AfricanAmerican-vs-Asian
8.507200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.614400E-01
Normal-vs-Female
3.787400E-01
Male-vs-Female
7.389000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.750000E-01
Normal-vs-Age(41-60Yrs)
5.775400E-01
Normal-vs-Age(61-80Yrs)
2.886800E-01
Normal-vs-Age(81-100Yrs)
3.082400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.262800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.463600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.856400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.505220E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.727800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.926600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.395600E-01
Normal-vs-Daily Drinker
4.911600E-01
Normal-vs-Weekly Drinker
5.383200E-01
Normal-vs-Occasional Drinker
3.775400E-01
Normal-vs-Social Drinker
9.703200E-01
Non Drinker-vs-Daily Drinker
9.138200E-01
Non Drinker-vs-Weekly Drinker
9.585200E-01
Non Drinker-vs-Occasional Drinker
8.194800E-01
Non Drinker-vs-Social Drinker
2.677400E-01
Daily Drinker-vs-Weekly Drinker
9.674600E-01
Daily Drinker-vs-Occasional Drinker
9.035200E-01
Daily Drinker-vs-Social Drinker
3.052000E-01
Weekly Drinker-vs-Occasional Drinker
8.768800E-01
Weekly Drinker-vs-Social Drinker
3.530600E-01
Occasional Drinker-vs-Social Drinker
2.595800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.884380E-01
Normal-vs-Grade 2
9.227900E-02
Normal-vs-Grade 3
1.320960E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.865500E-02
Grade 1-vs-Grade 3
8.820400E-03
Grade 1-vs-Grade 4
1.884380E-01
Grade 2-vs-Grade 3
1.280650E-01
Grade 2-vs-Grade 4
9.227900E-02
Grade 3-vs-Grade 4
1.320960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.476820E-01
Normal-vs-NonDiabetic
5.119400E-01
Diabetic-vs-NonDiabetic
4.200200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.612600E-01
Normal-vs-NoPancreatitis
2.860000E-01
Pancreatitis-vs-NoPancreatitis
1.675650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.903600E-01
Normal-vs-N1
3.564200E-01
N0-vs-N1
5.894200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.913600E-01
Normal-vs-TP53-NonMutant
3.739200E-01
TP53-Mutant-vs-TP53-NonMutant
9.154400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
